Which of the following medications is commonly prescribed to prevent stroke in patients with atrial fibrillation?

Questions 265

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan Questions

Question 1 of 5

Which of the following medications is commonly prescribed to prevent stroke in patients with atrial fibrillation?

Correct Answer: A

Rationale: The correct answer is A: Warfarin. Warfarin is commonly prescribed for stroke prevention in atrial fibrillation due to its ability to prevent blood clot formation by inhibiting clotting factors. Aspirin is less effective than warfarin for stroke prevention in atrial fibrillation. Metoprolol is a beta-blocker used for rate control in atrial fibrillation but does not directly prevent stroke. Heparin is a short-acting anticoagulant not typically used for long-term stroke prevention in atrial fibrillation.

Question 2 of 5

A 60-year-old male with hyperlipidemia is prescribed atorvastatin. Atorvastatin works by:

Correct Answer: B

Rationale: The correct answer is B: Inhibiting HMG-CoA reductase in the liver. Atorvastatin is a statin drug that works by inhibiting this enzyme, which plays a crucial role in the synthesis of cholesterol in the liver. By blocking this enzyme, atorvastatin reduces the production of cholesterol in the liver, leading to lower levels of LDL cholesterol in the bloodstream. Incorrect answers: A: Inhibiting the absorption of cholesterol in the intestines - This is the mechanism of action of drugs like ezetimibe, not atorvastatin. C: Increasing HDL cholesterol levels - Atorvastatin primarily lowers LDL cholesterol levels and has minimal effect on raising HDL cholesterol levels. D: Increasing the excretion of cholesterol in the bile - This is the mechanism of action of bile acid sequestrants, not atorvastatin.

Question 3 of 5

Which medication is commonly prescribed for the treatment of hypercholesterolemia by lowering LDL cholesterol levels?

Correct Answer: D

Rationale: Atorvastatin, simvastatin, and lovastatin are all statin medications commonly prescribed for hypercholesterolemia by lowering LDL cholesterol levels. They work by inhibiting an enzyme involved in cholesterol synthesis, thus reducing LDL levels. Choosing "All of the above" (D) is correct because all three medications are effective in treating hypercholesterolemia. The other choices are incorrect because each of them individually is a valid treatment option for lowering LDL cholesterol levels.

Question 4 of 5

Which of the following medications is commonly prescribed to reduce cholesterol by inhibiting HMG-CoA reductase?

Correct Answer: D

Rationale: The correct answer is D: All of the above. Atorvastatin, Simvastatin, and Lovastatin are all statin medications that work by inhibiting the enzyme HMG-CoA reductase, reducing cholesterol levels. These medications are commonly prescribed to lower LDL cholesterol and decrease the risk of cardiovascular events. Choosing D as the correct answer is appropriate because all the listed medications belong to the same class and function in the same way. Choices A, B, and C are incorrect individually because they are all valid options for medications that inhibit HMG-CoA reductase to reduce cholesterol levels.

Question 5 of 5

A 65-year-old female with chronic asthma is prescribed montelukast. Montelukast works by:

Correct Answer: A

Rationale: The correct answer is A: Blocking leukotriene receptors in the lungs. Montelukast is a leukotriene receptor antagonist, which works by blocking the action of leukotrienes, inflammatory mediators that cause bronchoconstriction and inflammation in asthma. By blocking leukotriene receptors, montelukast helps to reduce bronchoconstriction and inflammation in the lungs, thereby improving asthma symptoms. B: Relaxing bronchial smooth muscle by stimulating beta-2 adrenergic receptors is incorrect because montelukast does not directly stimulate beta-2 adrenergic receptors. C: Inhibiting the release of histamine from mast cells is incorrect because montelukast does not inhibit histamine release; it specifically targets leukotriene receptors. D: Increasing acetylcholine release in the lungs is incorrect because montelukast does not affect acetylcholine release.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions